Biogen

NASDAQ
BIIB
Stock
Yield per half year: -9.75%
Dividend yield: 0%
Sector: Healthcare

127.5 $

-5.61 $ -4.21%
113.38 $
227.44 $

Min/max per year

Share chart Biogen

About Biogen

Biogen Inc. — американская многонациональная биотехнологическая компания, базирующаяся в Кембридже, штат Массачусетс, специализирующаяся на открытии, разработке и поставке методов лечения нейродегенеративных, гематологических и аутоиммунных заболеваний пациентам во всем мире.

Main settings

IPO date
1991-09-16
ISIN
US09062X1037
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Дивиденд ао
22.23
Сайт

Grade

Underestimation
Title Value Grade
P/S 2.26 6
P/BV 1.31 9
P/E 13.43 8
Efficiency
Title Value Grade
ROA 5.95 2
ROE 10.36 4
ROIC 8.77 3
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0.5 5
Average dividend growth 0 0
Debt
Title Value Grade
Debt/EBITDA 2.55 5
Debt/Ratio 0.2364 10
Debt/Equity 0.678 9
Growth impulse
Title Value Grade
Yield Revenue, % -28.01 0
Yield Ebitda, % -68.39 0
Yield EPS, % -54.89 0

Prices

Price Min. Max. Change Changes in the industry Changes in the index
Yesterday 133.11 $ 0 $ 0 $ -4.21 % 0 % 0 %
Week 134.46 $ 127.5 $ 133.11 $ -5.18 % 0 % 0 %
Month 133.06 $ 124.76 $ 135.33 $ -4.18 % 0 % 0 %
Three month 120.17 $ 116.49 $ 135.49 $ +6.1 % 0 % 0 %
Half a year 141.27 $ 113.38 $ 150.71 $ -9.75 % 0 % 0 %
Year 195.81 $ 113.38 $ 227.44 $ -34.89 % 0 % 0 %
3 years 266.67 $ 113.38 $ 324.5 $ -52.19 % 0 % 0 %
5 years 279.75 $ 113.38 $ 422.32 $ -54.42 % 0 % 0 %
10 years 287.38 $ 113.38 $ 422.32 $ -55.63 % 0 % 0 %
Year to date 139.39 $ 113.38 $ 153.27 $ -8.53 % 0 % 0 %

Insider trading

Main owners

Contained in ETF

Similar companies



Company management

Head Job title Payment Year of birth
Ms. Robin C. Kramer Senior VP & Chief Accounting Officer N/A 1966 (59 years)
Ms. Natacha Gassenbach Chief Communication Officer & Head of Corporate Affairs N/A
Ms. Nicole Murphy Head of Pharmaceutical Operations & Technology 1.46M 1973 (52 years)
Mr. Michael R. McDonnell CPA Executive VP & CFO 2.12M 1964 (61 year)
Ms. Susan H. Alexander Esq. Executive VP & Chief Legal Officer 2.2M 1957 (68 years)
Mr. Christopher A. Viehbacher President, CEO & Director 487.94k 1961 (64 years)
Mr. Charles E. Triano Senior VP & Head of Investor Relations N/A
Mr. Adam Keeney Ph.D. Executive VP & Head of Corporate Development N/A 1977 (48 years)
Mr. Rachid Izzar Head of Global Product Strategy & Commercialization 1975 (50 years)
Dr. Ginger Gregory Ph.D. Executive VP & Chief Human Resources Officer 1968 (57 years)

About company

Address: United States, Cambridge, 225 Binney Street - Open in google maps, Open in yandex maps
Website: http://www.biogen.com